Related Experiment Video
Updated: May 26, 2026
10:49
Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
Published on: August 21, 2021
Using a diagnostic tool to identify elevated protease activity levels in chronic and stalled wounds: a consensus
Robert J Snyder1, Vickie Driver, Caroline E Fife
1Systagenix Wound Care, Quincy, MA, USA. drwound@aol.com
Ostomy/Wound Management
|December 14, 2011
Summary
A new point-of-care protease test could significantly improve chronic wound care. Experts agree this diagnostic tool could better target treatments for nonhealing wounds, enhancing patient outcomes.
Area of Science:
- Wound Healing Research
- Biomarker Diagnostics
- Protease Activity Measurement
Background:
- Chronic wound care lacks diagnostic tools to guide treatment decisions.
- High protease levels correlate with nonhealing wounds, indicating a need for diagnostic tests.
- Patient factors, comorbidities, and the wound microenvironment influence healing outcomes.
Framework:
- Consensus among seven wound care experts on a point-of-care protease test.
- Agreement that disease states do not automatically impede healing.
- Recognition that multiple factors affect nonhealing risk.
Implementation:
- Experts emphasized the importance of appropriate protease activity in wound healing.
- Measuring a single protease is insufficient to represent the wound's proteolytic environment.
- Currently, no diagnostic tests exist for high protease activity in wounds.
Implications:
- A simple, accessible protease diagnostic test could revolutionize wound care, especially in outpatient settings.
- Confirmation of high protease activity could guide targeted protease-modulating therapies for stalled wounds.
- Extensive validation through clinical trials is crucial to demonstrate improved patient outcomes.
